AGP Picks
View all

Today on the Internet: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.

Press releases published on July 1, 2026

250th Anniversary of the American Declaration of Independence
Virtune erweitert den Virtune Stablecoin Index ETP um vier neue Krypto-Assets: BNB (BNB), Canton (CC), Ethena (ENA) und TRON (TRX)
Virtune adds four new crypto assets to the Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX), and BNB (BNB)
Virtune lisää neljä uutta kryptovaraa Virtune Stablecoin Index ETP:hen: Ethena (ENA), Canton (CC), TRON (TRX) ja BNB (BNB)
Virtune inkluderar fyra nya kryptotillgångar i Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX) och BNB (BNB)
Purebase Announces Keystone Mine Permitted and Operational
Kandi Technologies’ Subsidiary Xinchu New Energy Named Authorized Distributor of Schneider Electric
Airwheel Launches Smart Suitcase Redefining Travel Mobility: AI Suitcase, Electric Suitcase and Rideable Cabin Suitcase for the Next Era of Boarding Luggage
200+ Brands, 100+ Speakers Confirmed for Forex Expo Dubai 2026
EUR 200 million share buyback begins following completion of EUR 227 million share buyback
Vocalbeats.AI Joins SGTech’s Singapore Enterprise Chapter
Press Release: Availability of the aide-mémoire for Q2 2026 results
Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire »
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment
Nicox : Demande d’autorisation de mise sur le marché de NCX 470 soumise aux Etats-Unis par Kowa, avec un paiement d’étape de 3 millions d’euros associé
Santhera gibt Topline-Ergebnisse der klinischen Phase-1-Studie von Catalyst Pharmaceuticals zu AGAMREE® bekannt
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
Ipsen va acquérir Memo Therapeutics AG, élargissant son portefeuille de maladies rares grâce à l’ajout d’un anticorps premier de sa classe ciblant le polyomavirus BK   
Forward Industries, Inc (“Forward”) - Rule 2.12 Announcement

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today on the Internet

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.